Schedule 13D ownership disclosure
AILERON THERAPEUTICS INC
Security class unavailable · CUSIP: 00887A105
Event date: 2019-08-13
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001144204-19-039589
- Form type
- SC 13D
- Filer
- Rein Therapeutics, Inc.
- CIK
- CIK 1420565
- Filed
- Aug 13, 2019
- Reporting period
- Aug 13, 2019
- Description
- Schedule 13D beneficial ownership